Author: 0526bmf1980

In this edition of The Onco’Zine Brief Peter Hofland talks with Holly LaDuca, a certified genetic counselor and manager of clinical Research oncology at Ambry Genetics.

Identifying an individual’s genetic information is nothing new. And while, over…

In this episode of the Onco’Zine Brief Peter Hofland reports from the 2019 annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019.

Hofland talks with:

– Dr. Hartmut Juhl, the Chief Executive…

In this episode of The Onco’Zine Brief, recorded during the annual meeting of the American Society of Clinical Oncology, ASCO, being held May 31 – June 4, 2019, Peter Hofland talks with Lee Schwartzberg MD, FACP, is a Medical Oncologist and…

In this episode of The Onco’Zine Brief Peter Hofland report from the annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019.

The American Society of Clinical Oncology is the world’s leading…

This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Eugene Luskin, Chief Executive Officer…

This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019.

In this episode Peter Hofland talks with a Adil Akhtar, MD, an Oncologist and…

In this edition of The Onco’Zine Brief Peter Hofland talks with Mr. Isaac Israel, the CEO of Kitov Pharma, a pharmaceutical drug development company developing new options to treat osteoarthritis pain and hypertension simultaneously, as well as novel…

In this edition of The Onco’Zine Brief Peter Hofland talk with Dr. Lisa Stearns, the founder and medical director of Center for Pain and Supportive Care, in Phoenix, Arizona.

An internationally recognized Interventional Pain Specialist, board…

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Salman Hyder, Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center at the…

In this edition of The Onco’Zine Brief Peter Hofland talks with Greg Van Wyk, Chief Executive Officer and Chief Medical Officer of Noxopharm, a clinical-stage Australian drug development company with offices in Sydney, New York and Hong Kong.

The…

In this edition of The Onco’Zine Brief Peter Hofland talks with Charlie Covert, Vice President & General Manager Targeted Drug Delivery, Restorative Therapies Group – Pain Division at Medtronic, about opioids and pain management in patients with…

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Kenneth Vega, chief of Gastroenterology and co-director of the Digestive Health Center at Augusta University Health, a public research university and academic medical center located…

In this edition of The Onco’Zine Brief Peter Hofland talks with Padma Sundar.

Ms. Sundar is Vice President of Strategy and Market Access at CellMax Life, a company developing a simple blood test or liquid biopsy for cancer screening. The company is…

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most…

In this edition of The Onco’Zine Brief Peter Hofland talks with Robert Goff about Medical Debt. Goff is one of the co-authors of a new book (“End Medical Debt: Curing America’s $1 Trillion Unpayable Healthcare Debt”) about the subject. He co-authored…

This week in The Onco’Zine Brief Peter Hofland, Ph.D talks with Guy Chamberland, M.Sc., Ph.D, about medicinal cannabis.

Chamberland, is a Master Herbalist as well as Chief Executive Officer and Chief Scientific Officer of Tetra Bio-Pharma, a…

In the third and final part of a 3-part series about colorectal cancer, developed in collaboration with the online journal OncoZine at www.oncozine.com, Peter Hofland, PhD. talks with Paul J. Berggreen, MD and Daniel M. Jondle, MD, both from Arizona…

In the second part of a 3-part series about colorectal cancer, developed in collaboration with the online journal OncoZine at www.oncozine.com, Peter Hofland, PhD. talks with Paul J. Berggreen, MD and Daniel M. Jondle, MD, both from Arizona Digestive…

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Paul Berggreen and Dr. Daniel Jondle, both from Arizona Digestive Health, in Phoenix, Arizona, about Colorectal Cancer.

Today’s program is the first of a 3-part series about the…

In this edition of The Onco’Zine Brief Peter Hofland talks with Charlie Johnson, Chief Executive Officer of ADC Bio, a biotechnology company, specialized in the development of Antibody-drug Conjugates.

Antibody-drug Conjugates, also known as ADCs,…